Novoxel Inc.

Novoxel Inc. is an Israel-based medical equipment manufacturer specializing in non-invasive aesthetic and ophthalmic treatments using proprietary Thermo-Mechanical Action (TMA®) technology. The company's flagship Tixel® device platform delivers fractional thermal energy via a medical-grade titanium tip for skin rejuvenation and dry eye disease treatment without lasers, needles, or ablation. The Tixel i® is FDA-cleared for treating Meibomian Gland Dysfunction and evaporative dry eye, offering a 2-minute treatment protocol. The aesthetic line (Tixel 2 and Tixel C) addresses wrinkles, scars, acne, melasma, stretch marks, and periorbital aging across all skin types with minimal downtime. Clinically validated through peer-reviewed publications, Tixel is marketed to dermatologists, ophthalmologists, aesthetic practitioners, and eye care specialists globally, with U.S. distribution through GPOphtho.